Cytosorbents financial statements

사이토소벤츠NASDAQ:CTSO · Nasdaq · Healthcare · sector #17
$3.96-0.13%
2026-10-06 close

Cytosorbents's published financial data is dated 2026-10-04. 2024 revenue was $36M. 2024 operating profit was −$17M.

Reported results

Cytosorbents notifications

Quantus Signal · live data · not investment advice · Privacy Policy